Home > PE Ratio > AURO LABORATORIES

AURO LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of AURO LABORATORIES is 132.15.

Share Price ₹225.3Feb 02,2026
Market Cap ₹139.7 Cr
Earnings-TTM₹1.1 CrTTM-Standalone Results
Price/Earnings132.15xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
AURO LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of AURO LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AURO LABORATORIES is calculated as :

Current Market Cap [ ₹139.7 Cr] as on Feb 02,2026

(/) Earnings [ ₹1.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 132.15x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AURO LABORATORIES , the investors are currently willing to pay 132.15 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AURO LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AURO LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of AURO LABORATORIES


PE Ratio Performance Analysis for AURO LABORATORIES

- AURO LABORATORIES 's latest p/e ratio is 132.15x.

- AURO LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 26.80x.

- AURO LABORATORIES 's operated at median p/e ratio of 13.95x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AURO LABORATORIES 's p/e ratio peaked in Mar2025 at 78.15x.

- AURO LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 7.04x.


How does AURO LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AURO LABORATORIES 1.06132.15139.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4035.53390,828.0
DIVIS LABORATORIES LTD2,485.0063.67158,227.0
CIPLA LTD4,544.7023.32105,961.0
TORRENT PHARMACEUTICALS LTD2,140.0063.11135,045.0
DR REDDYS LABORATORIES LTD5,508.7017.9198,682.5
MANKIND PHARMA LTD1,767.0648.2985,330.9
ZYDUS LIFESCIENCES LTD4,973.4017.7988,473.1
LUPIN LTD4,347.5322.3797,270.2
AUROBINDO PHARMA LTD3,447.7519.8068,250.0
ABBOTT INDIA LTD1,508.9538.4758,046.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AURO LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.79x
Max industry PE 132.15x
Median industry PE 35.53x
Average industry PE 43.85x



You may also like the below Video Courses